Pcr Methode Legionella

Human Legionella antibody(IgG) ELISA Kit

CSB-E05015h-24T 1 plate of 24 wells
EUR 198
Description: Quantitativesandwich ELISA kit for measuring Human Legionella antibody (IgG) in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human IgG antibody Laboratories manufactures the pcr methode legionella reagents distributed by Genprice. The Pcr Methode Legionella reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Legionella PCR. Other Pcr products are available in stock. Specificity: Pcr Category: Methode Group: Legionella

Human True insulin ELISA kit

1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Legionella Pneumophila IgG ELISA Kit (Human) (OKNA00152)

96 Wells
EUR 505.2
Description: Description of target: Legionellae are aerobic gram-negative facultative intracellular parasites of certain protozoa. They are found in freshwater environments worldwide and can cause respiratory disease (legionellosis) in humans. Legionella was first identified after an outbreak of pneumonia involving delegates of the 1976 American Legion Convention at a Philadelphia hotel. The genus Legionella currently has at least 50 species comprising 70 distinct serogroups. One species of Legionella, L. pneumophila, is the aetiological agent of approximately 90 % of legionellosis cases, and serogroup 1 (Sg1) accounts for about 84 % of these cases. L. pneumophila multiplies itself at temperatures between 25 and 42 C, with an optimal growth temperature of 35 C. Legionella thrives in warm, stagnant water in the environment and in artificial systems such as cooling towers, evaporative condensers, hot and cold water systems and spa pools that mimic the natural environment in which the organism thrives. These systems also provide the means by which aerosols/droplets are generated and the organism dispersed into the atmosphere. Legionellosis can be acquired by the inhalation of aerosols containing Legionella bacteria or by micro-aspiration of ingested water contaminated with Legionella. Person-to-person transmission is not thought to be a risk. The likelihood of contracting Legionnaires' disease depends on the level of contamination in the water source, the susceptibility of the person exposed, and the intensity of exposure. Legionnaires' disease is characterized as an "opportunistic" disease that attacks individuals who have an underlying illness or a weakened immune system. Predisposing risks include increasing age, being male, heavy smoking, alcohol abuse, chronic lung disease, immunosuppressive therapy, cancer chemotherapy, organ or bone marrow transplant, and corticosteroid therapy. Legionellosis can appear in two distinct clinical presentations: Legionella pneumonia (Legionnaires’ disease) with an incubation period of approx. 2-10 days (may extend up to 16-20 days) and Pontiac fever (incubation period: normally 12-48 hours). Legionella pneumonia (Legionnaires’ disease) is a serious form of pneumonia that carries with it a case-fatality ratio of 10-15 %. Legionnaires’ disease patients initially present with cough, fever and nonspecific symptoms including malaise, myalgia and headache. Some patients develop shaking chills, chest pain, diarrhea, delirium or other neurologic symptoms. Extra pulmonary involvement is rare. Pontiac fever is a milder form of the disease without manifestations of pneumonia and presents as an influenza-like illness. Symptoms may include headache, chills, muscle aches, a dry cough and fever. It is usually self-limiting and typically does not require treatment. The attack rate is much higher than for Legionnaires’ disease (up to 95 % of those exposed).;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Reverse Capture Sandwich ELISA ;Sensitivity: Sensitivity is determined as the probability of the assay indicating a positive score in samples with the specific analyte present: > 90%

True north Cryobox 0.2mLNatural

EUR 172.8

True north Cryobox 0.5mLNatural

EUR 153.6

True north Cryobox1.5/2mLNatural

EUR 100.8

True north Cryobox 5mLNatural

EUR 153.6

True north Cryobox 5mLBlue

EUR 153.6

Legionella information

QPCR Kit DNA Legionella

EUR 1045.79


B02-103-10kg 10 kg
EUR 60


B02-103-2Kg 2 Kg
EUR 908.4


B02-103-500g 500 g
EUR 364.8

Human Legionella ELISA Kit

DEIA1721 96T
EUR 854.4
Description: The Legionella ELISA Test is an enzyme-linked immunosorbent assay for the qualitative detection of total antibody (IgG, IgM, IgA) to Legionella pneumophila serogroups 1 - 6 in human sera.

Legionella BCYE medium with

254543 PK120
EUR 256.8

Legionella spp. Antibody (HRP)

abx415706-1ml 1 ml
EUR 910.8

Legionella micadadei antibody

20C-CR1164RF 2 ml
EUR 289.2
Description: Rabbit polyclonal Legionella micadadei antibody

Legionella pneumophila protein

30-1321 1 mg
EUR 354
Description: Purified native Legionella pneumophila protein

Legionella pneumophila protein

30-1323 1 ml
EUR 289.2
Description: Purified native Legionella pneumophila protein

Legionella Pneumophila Protein

abx061479-01ml 0.1 ml
EUR 777.6

QPCR Kit DNA Legionella Mmix

EUR 1333.02

QPCR Kit DNA Legionella Mmix

EUR 1282.8

Legionella pneumophila antibody

10-L45B1 100 ug
EUR 337.2
Description: Mouse monoclonal Legionella pneumophila antibody

Legionella pneumophila antibody

10-L45D 100 ug
EUR 462
Description: Mouse monoclonal Legionella pneumophila antibody

Legionella pneumophila antibody

20-LR45 1 ml
EUR 434.4
Description: Rabbit polyclonal Legionella pneumophila antibody

Legionella pneumophila Antibody

abx023081-1ml 1 ml
EUR 878.4